%PDF-1.4
%
1120 0 obj
2596
endobj
1116 0 obj
13
endobj
1117 0 obj
13
endobj
1118 0 obj
11
endobj
1119 0 obj
10
endobj
1112 0 obj
609
endobj
1113 0 obj
26150
endobj
1114 0 obj
359
endobj
1115 0 obj
3816
endobj
1108 0 obj
724
endobj
1109 0 obj
39036
endobj
1110 0 obj
597
endobj
1111 0 obj
19790
endobj
1104 0 obj
2100
endobj
1105 0 obj
435
endobj
1106 0 obj
30857
endobj
1107 0 obj
12518
endobj
1100 0 obj
2287
endobj
1101 0 obj
1678
endobj
1102 0 obj
2119
endobj
1103 0 obj
1648
endobj
1096 0 obj
1939
endobj
1097 0 obj
2138
endobj
1098 0 obj
2274
endobj
1099 0 obj
2156
endobj
1092 0 obj
1972
endobj
1093 0 obj
1983
endobj
1094 0 obj
2034
endobj
1095 0 obj
2083
endobj
1088 0 obj
2424
endobj
1089 0 obj
2046
endobj
1090 0 obj
2168
endobj
1091 0 obj
2308
endobj
1084 0 obj
2497
endobj
1085 0 obj
2139
endobj
1086 0 obj
2498
endobj
1087 0 obj
2675
endobj
1080 0 obj
3106
endobj
1081 0 obj
2131
endobj
1082 0 obj
1998
endobj
1083 0 obj
2089
endobj
1076 0 obj
13
endobj
1077 0 obj
13
endobj
1078 0 obj
13
endobj
1079 0 obj
4460
endobj
1072 0 obj
615
endobj
1073 0 obj
675
endobj
1074 0 obj
2898
endobj
1075 0 obj
13
endobj
1068 0 obj
3469
endobj
1069 0 obj
2578
endobj
1070 0 obj
13
endobj
1071 0 obj
13
endobj
1064 0 obj
3224
endobj
1065 0 obj
3626
endobj
1066 0 obj
13
endobj
1067 0 obj
13
endobj
1060 0 obj
13
endobj
1061 0 obj
3462
endobj
1062 0 obj
13
endobj
1063 0 obj
13
endobj
1056 0 obj
4269
endobj
1057 0 obj
13
endobj
1058 0 obj
13
endobj
1059 0 obj
13
endobj
1052 0 obj
13
endobj
1053 0 obj
13
endobj
1054 0 obj
13
endobj
1055 0 obj
13
endobj
1048 0 obj
13
endobj
1049 0 obj
13
endobj
1050 0 obj
13
endobj
1051 0 obj
13
endobj
1044 0 obj
13
endobj
1045 0 obj
13
endobj
1046 0 obj
4046
endobj
1047 0 obj
13
endobj
1040 0 obj
13
endobj
1041 0 obj
13
endobj
1042 0 obj
13
endobj
1043 0 obj
3302
endobj
1036 0 obj
13
endobj
1037 0 obj
13
endobj
1038 0 obj
13
endobj
1039 0 obj
13
endobj
1032 0 obj
13
endobj
1033 0 obj
13
endobj
1034 0 obj
13
endobj
1035 0 obj
13
endobj
1028 0 obj
13
endobj
1029 0 obj
13
endobj
1030 0 obj
3121
endobj
1031 0 obj
13
endobj
1024 0 obj
13
endobj
1025 0 obj
13
endobj
1026 0 obj
13
endobj
1027 0 obj
13
endobj
1020 0 obj
4060
endobj
1021 0 obj
13
endobj
1022 0 obj
13
endobj
1023 0 obj
13
endobj
1016 0 obj
13
endobj
1017 0 obj
13
endobj
1018 0 obj
13
endobj
1019 0 obj
13
endobj
1012 0 obj
13
endobj
1013 0 obj
13
endobj
1014 0 obj
13
endobj
1015 0 obj
3672
endobj
1008 0 obj
3339
endobj
1009 0 obj
3316
endobj
1010 0 obj
13
endobj
1011 0 obj
13
endobj
1004 0 obj
2985
endobj
1005 0 obj
3580
endobj
1006 0 obj
13
endobj
1007 0 obj
13
endobj
1000 0 obj
13
endobj
1001 0 obj
13
endobj
1002 0 obj
13
endobj
1003 0 obj
13
endobj
996 0 obj
3366
endobj
997 0 obj
3458
endobj
998 0 obj
3253
endobj
999 0 obj
13
endobj
992 0 obj
3065
endobj
993 0 obj
13
endobj
994 0 obj
2679
endobj
995 0 obj
2805
endobj
988 0 obj
2685
endobj
989 0 obj
3294
endobj
990 0 obj
13
endobj
991 0 obj
4003
endobj
984 0 obj
13
endobj
985 0 obj
13
endobj
986 0 obj
13
endobj
987 0 obj
13
endobj
980 0 obj
13
endobj
981 0 obj
13
endobj
982 0 obj
13
endobj
983 0 obj
13
endobj
976 0 obj
13
endobj
977 0 obj
13
endobj
978 0 obj
13
endobj
979 0 obj
13
endobj
972 0 obj
13
endobj
973 0 obj
1118
endobj
974 0 obj
13
endobj
975 0 obj
13
endobj
968 0 obj
13
endobj
969 0 obj
13
endobj
970 0 obj
463
endobj
971 0 obj
13
endobj
964 0 obj
13
endobj
965 0 obj
13
endobj
966 0 obj
13
endobj
967 0 obj
13
endobj
960 0 obj
13
endobj
961 0 obj
13
endobj
962 0 obj
13
endobj
963 0 obj
13
endobj
956 0 obj
13
endobj
957 0 obj
13
endobj
958 0 obj
13
endobj
959 0 obj
13
endobj
952 0 obj
13
endobj
953 0 obj
13
endobj
954 0 obj
13
endobj
955 0 obj
13
endobj
948 0 obj
13
endobj
949 0 obj
13
endobj
950 0 obj
13
endobj
951 0 obj
13
endobj
944 0 obj
13
endobj
945 0 obj
13
endobj
946 0 obj
13
endobj
947 0 obj
13
endobj
940 0 obj
13
endobj
941 0 obj
13
endobj
942 0 obj
13
endobj
943 0 obj
13
endobj
936 0 obj
13
endobj
937 0 obj
13
endobj
938 0 obj
13
endobj
939 0 obj
13
endobj
932 0 obj
13
endobj
933 0 obj
13
endobj
934 0 obj
13
endobj
935 0 obj
13
endobj
928 0 obj
13
endobj
929 0 obj
13
endobj
930 0 obj
13
endobj
931 0 obj
13
endobj
924 0 obj
13
endobj
925 0 obj
13
endobj
926 0 obj
13
endobj
927 0 obj
13
endobj
920 0 obj
13
endobj
921 0 obj
13
endobj
922 0 obj
13
endobj
923 0 obj
13
endobj
916 0 obj
13
endobj
917 0 obj
13
endobj
918 0 obj
13
endobj
919 0 obj
13
endobj
912 0 obj
13
endobj
913 0 obj
13
endobj
914 0 obj
13
endobj
915 0 obj
13
endobj
908 0 obj
13
endobj
909 0 obj
13
endobj
910 0 obj
13
endobj
911 0 obj
13
endobj
904 0 obj
13
endobj
905 0 obj
13
endobj
906 0 obj
13
endobj
907 0 obj
3240
endobj
900 0 obj
13
endobj
901 0 obj
13
endobj
902 0 obj
13
endobj
903 0 obj
13
endobj
896 0 obj
13
endobj
897 0 obj
13
endobj
898 0 obj
13
endobj
899 0 obj
13
endobj
892 0 obj
13
endobj
893 0 obj
13
endobj
894 0 obj
13
endobj
895 0 obj
13
endobj
888 0 obj
13
endobj
889 0 obj
13
endobj
890 0 obj
13
endobj
891 0 obj
13
endobj
884 0 obj
13
endobj
885 0 obj
13
endobj
886 0 obj
13
endobj
887 0 obj
13
endobj
880 0 obj
13
endobj
881 0 obj
13
endobj
882 0 obj
13
endobj
883 0 obj
13
endobj
876 0 obj
13
endobj
877 0 obj
13
endobj
878 0 obj
13
endobj
879 0 obj
13
endobj
872 0 obj
13
endobj
873 0 obj
13
endobj
874 0 obj
13
endobj
875 0 obj
13
endobj
868 0 obj
13
endobj
869 0 obj
13
endobj
870 0 obj
13
endobj
871 0 obj
13
endobj
864 0 obj
13
endobj
865 0 obj
13
endobj
866 0 obj
13
endobj
867 0 obj
13
endobj
860 0 obj
13
endobj
861 0 obj
13
endobj
862 0 obj
13
endobj
863 0 obj
13
endobj
856 0 obj
13
endobj
857 0 obj
13
endobj
858 0 obj
13
endobj
859 0 obj
13
endobj
852 0 obj
13
endobj
853 0 obj
13
endobj
854 0 obj
13
endobj
855 0 obj
13
endobj
848 0 obj
13
endobj
849 0 obj
13
endobj
850 0 obj
13
endobj
851 0 obj
13
endobj
844 0 obj
1206
endobj
845 0 obj
1140
endobj
846 0 obj
3031
endobj
847 0 obj
13
endobj
840 0 obj
<<
/A 299 0 R
/Count 0
/Next 841 0 R
/Prev 839 0 R
/Parent 834 0 R
/Title (Appendix 4\tCriteria for Identifying Vital Signs of Potentially Clinically Significant)
/F 0
/C [0 0 0]
>>
endobj
841 0 obj
<<
/A 291 0 R
/Count 0
/Next 842 0 R
/Prev 840 0 R
/Parent 834 0 R
/Title (Appendix 5\tList of Summary Tables and Figures)
/F 0
/C [0 0 0]
>>
endobj
842 0 obj
<<
/A 71 0 R
/Count 0
/Prev 841 0 R
/Parent 834 0 R
/Title (Appendix 6\tList of Subject Data Listings)
/F 0
/C [0 0 0]
>>
endobj
843 0 obj
<<
/Type /Metadata
/Length 6925
/Subtype /XML
>>
stream
1000062620
IBA Katsuhiro
Aspose.PDF for Java 19.7; modified using OpenPDF 1.2.2
2021-06-16T00:59:14-04:00Aspose Ltd.2019-12-19T08:24:00Z
default171cac903-5407-4527-9138-606a8eca32a2
converted71cac903-5407-4527-9138-606a8eca32a2PDF/A conversion failed; Version and conformance level identification removedpdfEngine2021-06-16T10:28:08+09:00
http://ns.adobe.com/pdf/1.3/pdf
internalA name object indicating whether the document has been modified to include trapping informationTrappedTextAdobe PDF Schema
http://ns.adobe.com/xap/1.0/mm/xmpMM
internalUUID based identifier for specific incarnation of a documentInstanceIDURI
internalThe common identifier for all versions and renditions of a document.OriginalDocumentIDURIXMP Media Management Schema
http://www.aiim.org/pdfa/ns/id/pdfaid
internalPart of PDF/A standardpartInteger
internalAmendment of PDF/A standardamdText
internalConformance level of PDF/A standardconformanceTextPDF/A ID Schema
endstream
endobj
836 0 obj
<<
/A 289 0 R
/Count 0
/Next 837 0 R
/Prev 835 0 R
/Parent 834 0 R
/Title (Appendix 2\tScoring Instructions for MSQ)
/F 0
/C [0 0 0]
>>
endobj
837 0 obj
<<
/A 297 0 R
/Count 0
/Next 838 0 R
/Prev 836 0 R
/Parent 834 0 R
/Title (Table 15-1\tPrecoded and final item values for MSQ item responses)
/F 0
/C [0 0 0]
>>
endobj
838 0 obj
<<
/A 305 0 R
/Count 0
/Next 839 0 R
/Prev 837 0 R
/Parent 834 0 R
/Title (Table 15-2\tRaw score and transformation formula for each MSQ dimension)
/F 0
/C [0 0 0]
>>
endobj
839 0 obj
<<
/A 307 0 R
/Count 0
/Next 840 0 R
/Prev 838 0 R
/Parent 834 0 R
/Title (Appendix 3\tCriteria for Identifying Laboratory Values of Potentially Clinically Significant)
/F 0
/C [0 0 0]
>>
endobj
832 0 obj
<<
/A 290 0 R
/Count 0
/Next 833 0 R
/Prev 831 0 R
/Parent 771 0 R
/Title (13\tInterim Analysis)
/F 0
/C [0 0 0]
>>
endobj
833 0 obj
<<
/A 70 0 R
/Count 0
/Next 834 0 R
/Prev 832 0 R
/Parent 771 0 R
/Title (14\tChanges in the Planned Analyses)
/F 0
/C [0 0 0]
>>
endobj
834 0 obj
<<
/C [0 0 0]
/Parent 771 0 R
/A 8 0 R
/Last 842 0 R
/First 835 0 R
/Count 8
/Title (15\tReferences)
/Prev 833 0 R
/F 0
>>
endobj
835 0 obj
<<
/A 69 0 R
/Count 0
/Next 836 0 R
/Parent 834 0 R
/Title (Appendix 1\tLogics for Migraine Day Derivation)
/F 0
/C [0 0 0]
>>
endobj
828 0 obj
<<
/A 325 0 R
/Count 0
/Next 829 0 R
/Prev 827 0 R
/Parent 825 0 R
/Title (10.3\tHandling of Data)
/F 0
/C [0 0 0]
>>
endobj
829 0 obj
<<
/A 315 0 R
/Count 0
/Prev 828 0 R
/Parent 825 0 R
/Title (10.4\tStatistical Analysis Method)
/F 0
/C [0 0 0]
>>
endobj
830 0 obj
<<
/A 306 0 R
/Count 0
/Next 831 0 R
/Prev 825 0 R
/Parent 771 0 R
/Title (11\tPharmacodynamic Analyses)
/F 0
/C [0 0 0]
>>
endobj
831 0 obj
<<
/A 298 0 R
/Count 0
/Next 832 0 R
/Prev 830 0 R
/Parent 771 0 R
/Title (12\tPharmacogenomic Analyses)
/F 0
/C [0 0 0]
>>
endobj
824 0 obj
<<
/A 324 0 R
/Count 0
/Prev 823 0 R
/Parent 816 0 R
/Title (9.8\tElectronic Columbia-Suicide Severity Rating Scale)
/F 0
/C [0 0 0]
>>
endobj
825 0 obj
<<
/C [0 0 0]
/Parent 771 0 R
/A 309 0 R
/Last 829 0 R
/First 826 0 R
/Count 4
/Title (10\tPharmacokinetic Analyses)
/Prev 816 0 R
/Next 830 0 R
/F 0
>>
endobj
826 0 obj
<<
/A 313 0 R
/Count 0
/Next 827 0 R
/Parent 825 0 R
/Title (10.1\tEndpoint)
/F 0
/C [0 0 0]
>>
endobj
827 0 obj
<<
/A 321 0 R
/Count 0
/Next 828 0 R
/Prev 826 0 R
/Parent 825 0 R
/Title (10.2\tDataset for Analysis)
/F 0
/C [0 0 0]
>>
endobj
820 0 obj
<<
/A 344 0 R
/Count 0
/Next 821 0 R
/Prev 819 0 R
/Parent 816 0 R
/Title (9.4\tVital Sign and Weight Data)
/F 0
/C [0 0 0]
>>
endobj
821 0 obj
<<
/A 353 0 R
/Count 0
/Next 822 0 R
/Prev 820 0 R
/Parent 816 0 R
/Title (9.5\tPhysical Examination Data)
/F 0
/C [0 0 0]
>>
endobj
822 0 obj
<<
/A 343 0 R
/Count 0
/Next 823 0 R
/Prev 821 0 R
/Parent 816 0 R
/Title (9.6\tElectrocardiogram Data)
/F 0
/C [0 0 0]
>>
endobj
823 0 obj
<<
/A 333 0 R
/Count 0
/Next 824 0 R
/Prev 822 0 R
/Parent 816 0 R
/Title (9.7\tInjection Site Reactions)
/F 0
/C [0 0 0]
>>
endobj
816 0 obj
<<
/C [0 0 0]
/Parent 771 0 R
/A 314 0 R
/Last 824 0 R
/First 817 0 R
/Count 8
/Title (9\tSafety Analyses)
/Prev 798 0 R
/Next 825 0 R
/F 0
>>
endobj
817 0 obj
<<
/A 322 0 R
/Count 0
/Next 818 0 R
/Parent 816 0 R
/Title (9.1\tExtent of Exposure)
/F 0
/C [0 0 0]
>>
endobj
818 0 obj
<<
/A 329 0 R
/Count 0
/Next 819 0 R
/Prev 817 0 R
/Parent 816 0 R
/Title (9.2\tAdverse Events)
/F 0
/C [0 0 0]
>>
endobj
819 0 obj
<<
/A 336 0 R
/Count 0
/Next 820 0 R
/Prev 818 0 R
/Parent 816 0 R
/Title (9.3\tClinical Laboratory Data)
/F 0
/C [0 0 0]
>>
endobj
812 0 obj
<<
/A 360 0 R
/Count 0
/Next 813 0 R
/Prev 811 0 R
/Parent 809 0 R
/Title (8.3.3\tOther Headache-related Endpoints)
/F 0
/C [0 0 0]
>>
endobj
813 0 obj
<<
/A 359 0 R
/Count 0
/Next 814 0 R
/Prev 812 0 R
/Parent 809 0 R
/Title (8.3.4\tOther Efficacy Endpoints)
/F 0
/C [0 0 0]
>>
endobj
814 0 obj
<<
/A 352 0 R
/Count 0
/Prev 813 0 R
/Parent 809 0 R
/Title (8.3.5\tTechnical Computational Details for Exploratory Analysis)
/F 0
/C [0 0 0]
>>
endobj
815 0 obj
<<
/A 332 0 R
/Count 0
/Prev 809 0 R
/Parent 798 0 R
/Title (8.4\tSubgroup Analyses)
/F 0
/C [0 0 0]
>>
endobj
808 0 obj
<<
/A 346 0 R
/Count 0
/Prev 807 0 R
/Parent 806 0 R
/Title (8.2.2\tTechnical Computational Details for Secondary Analysis)
/F 0
/C [0 0 0]
>>
endobj
809 0 obj
<<
/C [0 0 0]
/Parent 798 0 R
/A 342 0 R
/Last 814 0 R
/First 810 0 R
/Count -5
/Title (8.3\tExploratory Endpoints)
/Prev 806 0 R
/Next 815 0 R
/F 0
>>
endobj
810 0 obj
<<
/A 351 0 R
/Count 0
/Next 811 0 R
/Parent 809 0 R
/Title (8.3.1\tNumber of Migraine Days)
/F 0
/C [0 0 0]
>>
endobj
811 0 obj
<<
/A 358 0 R
/Count 0
/Next 812 0 R
/Prev 810 0 R
/Parent 809 0 R
/Title (8.3.2\tNumber of Headache Days of at Least Moderate Severity)
/F 0
/C [0 0 0]
>>
endobj
804 0 obj
<<
/A 348 0 R
/Count 0
/Next 805 0 R
/Prev 801 0 R
/Parent 799 0 R
/Title (8.1.3\tSupplementary Analyses)
/F 0
/C [0 0 0]
>>
endobj
805 0 obj
<<
/A 339 0 R
/Count 0
/Prev 804 0 R
/Parent 799 0 R
/Title (8.1.4\tTechnical Computational Details for Primary Analysis)
/F 0
/C [0 0 0]
>>
endobj
806 0 obj
<<
/C [0 0 0]
/Parent 798 0 R
/A 337 0 R
/Last 808 0 R
/First 807 0 R
/Count -2
/Title (8.2\tSecondary Endpoint)
/Prev 799 0 R
/Next 809 0 R
/F 0
>>
endobj
807 0 obj
<<
/A 345 0 R
/Count 0
/Next 808 0 R
/Parent 806 0 R
/Title (8.2.1\tSecondary Analysis)
/F 0
/C [0 0 0]
>>
endobj
800 0 obj
<<
/A 338 0 R
/Count 0
/Next 801 0 R
/Parent 799 0 R
/Title (8.1.1\tPrimary Analysis)
/F 0
/C [0 0 0]
>>
endobj
801 0 obj
<<
/C [0 0 0]
/Parent 799 0 R
/A 347 0 R
/Last 803 0 R
/First 802 0 R
/Count 2
/Title (8.1.2\tSensitivity Analyses)
/Prev 800 0 R
/Next 804 0 R
/F 0
>>
endobj
802 0 obj
<<
/A 354 0 R
/Count 0
/Next 803 0 R
/Parent 801 0 R
/Title (8.1.2.1\tWilcoxon Rank-sum Test)
/F 0
/C [0 0 0]
>>
endobj
803 0 obj
<<
/A 355 0 R
/Count 0
/Prev 802 0 R
/Parent 801 0 R
/Title (8.1.2.2\tAnalysis With Multiple Imputation Method)
/F 0
/C [0 0 0]
>>
endobj
796 0 obj
<<
/A 350 0 R
/Count 0
/Next 797 0 R
/Prev 795 0 R
/Parent 791 0 R
/Title (7.5\tPrior and Concomitant Medications)
/F 0
/C [0 0 0]
>>
endobj
797 0 obj
<<
/A 341 0 R
/Count 0
/Prev 796 0 R
/Parent 791 0 R
/Title (7.6\tProtocol Deviations)
/F 0
/C [0 0 0]
>>
endobj
798 0 obj
<<
/C [0 0 0]
/Parent 771 0 R
/A 323 0 R
/Last 815 0 R
/First 799 0 R
/Count 4
/Title (8\tEfficacy Analysis)
/Prev 791 0 R
/Next 816 0 R
/F 0
>>
endobj
799 0 obj
<<
/C [0 0 0]
/Parent 798 0 R
/A 330 0 R
/Last 805 0 R
/First 800 0 R
/Count -6
/Title (8.1\tPrimary Endpoint)
/Next 806 0 R
/F 0
>>
endobj
792 0 obj
<<
/A 340 0 R
/Count 0
/Next 793 0 R
/Parent 791 0 R
/Title (7.1\tSubject Disposition)
/F 0
/C [0 0 0]
>>
endobj
793 0 obj
<<
/A 349 0 R
/Count 0
/Next 794 0 R
/Prev 792 0 R
/Parent 791 0 R
/Title (7.2\tDemographic and Baseline Characteristics)
/F 0
/C [0 0 0]
>>
endobj
794 0 obj
<<
/A 356 0 R
/Count 0
/Next 795 0 R
/Prev 793 0 R
/Parent 791 0 R
/Title (7.3\tBaseline Disease Evaluation)
/F 0
/C [0 0 0]
>>
endobj
795 0 obj
<<
/A 357 0 R
/Count 0
/Next 796 0 R
/Prev 794 0 R
/Parent 791 0 R
/Title (7.4\tTreatment Compliance)
/F 0
/C [0 0 0]
>>
endobj
788 0 obj
<<
/C [0 0 0]
/Parent 771 0 R
/A 326 0 R
/Last 790 0 R
/First 789 0 R
/Count 2
/Title (6\tPrimary and Secondary Endpoints:)
/Prev 785 0 R
/Next 791 0 R
/F 0
>>
endobj
789 0 obj
<<
/A 334 0 R
/Count 0
/Next 790 0 R
/Parent 788 0 R
/Title (6.1\tPrimary Endpoint)
/F 0
/C [0 0 0]
>>
endobj
790 0 obj
<<
/A 335 0 R
/Count 0
/Prev 789 0 R
/Parent 788 0 R
/Title (6.2\tSecondary Endpoints)
/F 0
/C [0 0 0]
>>
endobj
791 0 obj
<<
/C [0 0 0]
/Parent 771 0 R
/A 331 0 R
/Last 797 0 R
/First 792 0 R
/Count 6
/Title (7\tDisposition and Demographic Analysis)
/Prev 788 0 R
/Next 798 0 R
/F 0
>>
endobj
784 0 obj
<<
/A 310 0 R
/Count 0
/Next 785 0 R
/Prev 777 0 R
/Parent 771 0 R
/Title (4\tSample Size \(Cohort 2\))
/F 0
/C [0 0 0]
>>
endobj
785 0 obj
<<
/C [0 0 0]
/Parent 771 0 R
/A 316 0 R
/Last 787 0 R
/First 786 0 R
/Count 2
/Title (5\tStatistical Analysis Datasets)
/Prev 784 0 R
/Next 788 0 R
/F 0
>>
endobj
786 0 obj
<<
/A 327 0 R
/Count 0
/Next 787 0 R
/Parent 785 0 R
/Title (5.1\tAnalysis Sets)
/F 0
/C [0 0 0]
>>
endobj
787 0 obj
<<
/A 328 0 R
/Count 0
/Prev 786 0 R
/Parent 785 0 R
/Title (5.2\tHandling of Missing Data)
/F 0
/C [0 0 0]
>>
endobj
780 0 obj
<<
/A 317 0 R
/Count 0
/Next 781 0 R
/Prev 778 0 R
/Parent 777 0 R
/Title (3.2\tTrial Treatments)
/F 0
/C [0 0 0]
>>
endobj
781 0 obj
<<
/C [0 0 0]
/Parent 777 0 R
/A 312 0 R
/Last 783 0 R
/First 782 0 R
/Count -2
/Title (3.3\tTrial Population)
/Prev 780 0 R
/F 0
>>
endobj
782 0 obj
<<
/A 319 0 R
/Count 0
/Next 783 0 R
/Parent 781 0 R
/Title (3.3.1\tSubject Groups)
/F 0
/C [0 0 0]
>>
endobj
783 0 obj
<<
/A 320 0 R
/Count 0
/Prev 782 0 R
/Parent 781 0 R
/Title (3.3.2\tNumber of Subjects in Cohort 2)
/F 0
/C [0 0 0]
>>
endobj
776 0 obj
<<
/A 304 0 R
/Count 0
/Next 777 0 R
/Prev 775 0 R
/Parent 771 0 R
/Title (2\tTrial Objectives)
/F 0
/C [0 0 0]
>>
endobj
777 0 obj
<<
/C [0 0 0]
/Parent 771 0 R
/A 308 0 R
/Last 781 0 R
/First 778 0 R
/Count 3
/Title (3\tTrial Design)
/Prev 776 0 R
/Next 784 0 R
/F 0
>>
endobj
778 0 obj
<<
/C [0 0 0]
/Parent 777 0 R
/A 311 0 R
/Last 779 0 R
/First 779 0 R
/Count -1
/Title (3.1\tType/Design of Trial)
/Next 780 0 R
/F 0
>>
endobj
779 0 obj
<<
/A 318 0 R
/Count 0
/Parent 778 0 R
/Title (Figure 3.1-1\tTrial Design Schematic)
/F 0
/C [0 0 0]
>>
endobj
772 0 obj
<<
/A 7 0 R
/Count 0
/Next 773 0 R
/Parent 771 0 R
/Title (Table of Contents)
/F 0
/C [0 0 0]
>>
endobj
773 0 obj
<<
/A 68 0 R
/Count 0
/Next 774 0 R
/Prev 772 0 R
/Parent 771 0 R
/Title (List of Appendices)
/F 0
/C [0 0 0]
>>
endobj
774 0 obj
<<
/A 288 0 R
/Count 0
/Next 775 0 R
/Prev 773 0 R
/Parent 771 0 R
/Title (List of Abbreviations and Definition of Terms)
/F 0
/C [0 0 0]
>>
endobj
775 0 obj
<<
/A 296 0 R
/Count 0
/Next 776 0 R
/Prev 774 0 R
/Parent 771 0 R
/Title (1\tIntroduction)
/F 0
/C [0 0 0]
>>
endobj
768 0 obj
[769 0 R]
endobj
769 0 obj
<<
/RegistryName ()
/Type /OutputIntent
/OutputConditionIdentifier (Custom)
/S /GTS_PDFA1
/Info (sRGB IEC61966-2.1)
/DestOutputProfile 770 0 R
/OutputCondition (sRGB)
>>
endobj
770 0 obj
<<
/Filter /FlateDecode
/Length 1120 0 R
/Range [0 1 0 1 0 1]
/N 3
>>
stream
xwTSϽ7PkhRH
H.*1 J "6DTpDQ2(C"QDqpIdy͛~kg}ֺ LX Xňg` l pBF|،l *? Y"1 P\8=W%Oɘ4M0J"Y2Vs,[|e92<se'9`2&ctI@o|N6 (.sSdl-c(2-y H_/XZ.$&\SM07#1ؙYr fYym";8980m-m(]v^DW~
emi ]P`/ u}q|^R,g+\Kk)/C_|Rax8t1C^7nfzDp柇u$/ED˦L L[B@ٹЖX!@~ (* {d+}G͋љς}WL$cGD2QZ4 E@@ A(q`1D `'u46ptc48.`R0)
@Rt CXCP%CBH@Rf[(t
CQhz#0 Zl`O828.p|O×X
?:0FBx$ !i@ڐH[EE1PL⢖V6QP>U(j
MFk t,:.FW8c1L&ӎ9ƌaX:
rbl1
{{{;}#tp8_\8"Ey.,X%%Gщ1-9ҀKl.oo/O$&'=JvMޞ